Heel Warming Before Capillary Blood Sampling

NCT04995393 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2021-08-16

No results posted yet for this study

Summary

Capillary blood sampling from the heel is often used in the treatment of infants admitted to neonatal intensive care (NICU). In Danish NICUs a heated blanket, a heated gel pad or a disposable glove with warm water are the methods most often used.

The purpose of this randomized controlled study is to investigate which of the mentioned heating methods ensures the best quality of the blood sample and provides the most gentle blood sampling for the infant.

Conditions

  • Blood Specimen Collection

Interventions

PROCEDURE

Heating with a disposable glove containing water

Heating of the infants heel with a glove before blood sampling.

PROCEDURE

Heating with a blanket

Heating of the infants heel with a blanket before blood sampling.

PROCEDURE

Heating with a gel pack

Heating of the infants heel with a gel pack before blood sampling.

Sponsors & Collaborators

  • Region of Southern Denmark

    collaborator OTHER
  • Development and Innovation Fund at Lillebaelt Hospital

    collaborator UNKNOWN
  • The Research Council for Sygehus Lillebælt

    collaborator UNKNOWN
  • Sygekassernes Helsefond

    collaborator OTHER
  • The Biomedical Laboratory Scientist Education and Research Fund

    collaborator UNKNOWN
  • Kolding Sygehus

    lead OTHER

Principal Investigators

  • Jonna Skov Madsen · Clinical Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark

  • Patricia Diana Soerensen · Clinical Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark

  • Ulla List Toennesen · Clinical Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Hours
Max Age
77 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-26
Primary Completion
2021-02-12
Completion
2021-02-12

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04995393 on ClinicalTrials.gov